|
High $0.00 |
Low $0.00 |
Trades 3 |
Turnover $1,511 |
Volume 672,333 |
| 30 June 2023 at 1:49pm | ||||
|
Market Cap (4-Jul) $5,671,263 (1,275th) |
Close (30-Jun) $0.003 |
Volume (30-Jun) 672,333 |
Shortsold (23-Mar) 355,000 (0.00%) (603rd) |
|
52w High $0.077 |
52w Low $0.036 |
P/E - |
EPS 0 |
GTG released this announcement to the ASX on 1 August 2022, 8:17. The announcement is not marked as price sensitive, and is 30 page(s) in length and 2.07MB in size.
You can view all announcements from GTG and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from GTG | |
|---|---|
| Notification of cessation of securities - GTG | 10 May 2023, 13:54 |
| Updated Investor Presentation and Investor Webinar | 2 May 2023, 8:59 |
| Publication Validates geneType for Melanoma Risk Assessment | 28 April 2023, 9:02 |
| GeneType Business Update Presentation | 1 August 2022, 8:17 |
| Q4 FY22 Results Milestones and Growth | 28 July 2022, 8:30 |
| GeneType Risk Test Implemented in 9 Siles Health Clinics | 18 July 2022, 9:25 |
| Completion of AffinityDNA Acquisition | 14 July 2022, 9:47 |
You must be logged in to post a reply.
Genetic Technologies 